Loading stock data…
MMSI
$62.01-6.17 (-9.05%)
Market ClosedLast close May 1
Merit Medical Systems, Inc.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Merit Medical Systems, Inc. in the Healthcare sector is trading at $62.01. The stock is currently near its 52-week low of $61.31, remaining 23.8% below its 200-day moving average. Technical signals show oversold RSI of 30 and bearish MACD signal, explaining why MMSI maintains its current current market pressure. The Whystock Score of 50/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Oversold momentum (RSI 30) — potential for technical mean-reversion
Long-term trend bearish (Price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Whystock fair value is estimated using a trailing P/E model adjusted for return on equity: Fair P/E = 18 + (ROE × 20). Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. A base P/E of 18 represents a typical market multiple, scaled upward for companies that earn high returns on equity. The result is a theoretical "normalised" price — not a price target or investment advice. Large deviations are common for high-growth or loss-making companies.
Current Price$62.01
Potential Downside
40.4%
Whystock Fair Value$36.95
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Analyst Consensus11 analysts
Buy
Mean target$90.64+46.2%
Range$74.00 – $122.00
Fundamentals
Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States, China, Japan, Germany, France, the United Kingdom, and international...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$4.16B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
32.73
Beta
Defensive asset. Lower volatility than the S&P 500.
0.65
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
7.52%
Volume
Today's trading volume
2.53M
Recent News
MMSI Q1 Deep Dive: Oncology Expansion and Platform Realignment Drive Outlook
Medical device company Merit Medical Systems (NASDAQ:MMSI) announced better-than-expected revenue in Q1 CY2026, with sales up 7.5% year on year to $381.9 million. The company expects the full year’s revenue to be around $1.62 billion, close to analysts’ estimates. Its non-GAAP profit of $0.94 per share was 12.8% above analysts’ consensus estimates.
Merit Medical Q1 Earnings & Revenues Beat Estimates, Sales View Up
MMSI tops Q1 estimates with 9% EPS growth and 7% revenue rise, while lifting its 2026 sales outlook amid steady segment and geographic gains.
Merit Medical (MMSI) Q1 2026 Earnings Transcript
Martha Aronson: Thank you, operator, and welcome, everyone. Brian G. Lloyd: Thank you, Martha. This presentation contains forward-looking statements that receive Safe Harbor protection under federal securities laws.
Merit Medical Systems Inc (MMSI) Q1 2026 Earnings Call Highlights: Strong Revenue Growth and ...
Merit Medical Systems Inc (MMSI) reports a 7% revenue increase and strategic moves to expand market opportunities despite facing macroeconomic challenges.
Merit Medical Systems, Inc. Q1 2026 Earnings Call Summary
Moby summary of Merit Medical Systems, Inc.'s Q1 2026 earnings call